Drug: infliximab, recombinant Quarter: 2016Q3
Total Drug/Injury Combinations: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| INFLIXIMAB, RECOMBINANT | Stenotrophomonas infection | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Syndactyly | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Systemic lupus erythematosus | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Teratogenicity | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Testicular seminoma (pure) | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Thrombotic thrombocytopenic purpura | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Toxic skin eruption | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Treatment failure | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Treatment noncompliance | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Tuberculosis of central nervous system | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Type IV hypersensitivity reaction | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Upper respiratory tract infection | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Vascular malformation | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Vascular stent restenosis | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Viral infection | 1 | view events |
| INFLIXIMAB, RECOMBINANT | Visual acuity reduced | 1 | view events |
Total Drug/Injury Combinations: 276 Number of Pages: 14
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)